 ImmuCell NASDAQ: ICCC is one of 25 public companies in the Diagnostic substances industry, but how does it weigh in compared to its competitors? We will compare ImmuCell to related businesses based on the strength of its analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings. Earnings and Valuation This table compares ImmuCell and ... 